Status:
COMPLETED
Probiotics as a Prophylaxis to Prevent Clinical Manifestations of Oral Candidosis in Patients With Sjogren's Syndrome
Lead Sponsor:
Cairo University
Conditions:
Sjogren's Syndrome
Eligibility:
All Genders
30-70 years
Phase:
PHASE1
PHASE2
Brief Summary
Sjogren's syndrome is an autoimmune chronic disease. It has two forms Primary Sjogren's syndrome charactrized by dry eyes and dry mouth. Secondary Sjogren's syndrome characterized by rheumatoid diseas...
Eligibility Criteria
Inclusion
- primary or scondary Sjogren's syndrome
Exclusion
- allergy to milk derivatives previous intake of antifungals
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT03840538
Start Date
January 1 2018
End Date
January 1 2019
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt, 9112